SABBY MANAGEMENT, LLC - Q2 2021 holdings

$709 Million is the total value of SABBY MANAGEMENT, LLC's 162 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was - .

 Value Shares↓ Weighting
NewION GEOPHYSICAL CORPnote$319,845,0003,150,000
+100.0%
45.09%
COCP NewCOCRYSTAL PHARMA INC$7,638,0006,110,657
+100.0%
1.08%
ENOB NewENOCHIAN BIOSCIENCES INC$6,668,0001,341,663
+100.0%
0.94%
ATER NewATERIAN INC.$6,329,000433,000
+100.0%
0.89%
VXX NewBARCLAYS BANK PLCipth$5,615,000190,600
+100.0%
0.79%
RCON NewRECON TECHNOLOGY LTD$4,027,000930,000
+100.0%
0.57%
NewCANAAN INCput$3,050,0003,742
+100.0%
0.43%
NewMARATHON DIGITALput$2,861,000912
+100.0%
0.40%
NewATERIAN INCput$2,800,0001,914
+100.0%
0.40%
GLBS NewGLOBUS MARITIME LTD$2,718,000700,427
+100.0%
0.38%
NewBARCLAYS BANK PLCcall$2,578,000875
+100.0%
0.36%
KRBP NewKIROMIC BIOPHARMA INC$2,407,000500,508
+100.0%
0.34%
NewBIT BROTHER LTD$2,287,0001,039,458
+100.0%
0.32%
NewNEWAGE INCcall$2,255,00010,113
+100.0%
0.32%
KMPH NewKEMPHARM INC$2,207,000172,163
+100.0%
0.31%
ADOM NewADOMANI INC$1,821,0006,166,711
+100.0%
0.26%
BIIB NewBIOGEN INC$1,385,0004,000
+100.0%
0.20%
CVM NewCEL-SCI CORP$1,261,000145,285
+100.0%
0.18%
IKT NewINHIBIKASE THERAPEUTICS INC$1,179,000421,200
+100.0%
0.17%
AMPG NewAMPLITECH GROUP INC$1,061,000229,102
+100.0%
0.15%
NewATOSSA THERAPEUTICS INCcall$959,0001,517
+100.0%
0.14%
SBEVWS NewSPLASH BEVERAGE GROUP INC*w$947,000860,609
+100.0%
0.13%
MARA NewMARATHON DIGITAL$866,00027,590
+100.0%
0.12%
CBAT NewCBAK ENERGY TECH INC$825,000175,097
+100.0%
0.12%
METX NewMETEN EDTECHX EDUCATION LTDord$712,000733,840
+100.0%
0.10%
NewATHERSYS INC NEWcall$622,0004,321
+100.0%
0.09%
NewADAMIS PHARMACEUTICALS CORPput$568,0005,168
+100.0%
0.08%
NewGLOBUS MARITIME LTDput$543,0001,399
+100.0%
0.08%
New1847 GOEDEKER INCput$502,0001,305
+100.0%
0.07%
ATHX NewATHERSYS INC NEW$497,000345,400
+100.0%
0.07%
JOB NewGEE GROUP INC$401,000700,000
+100.0%
0.06%
GOEDWS New1847 GOEDEKER INC*w$385,000180,000
+100.0%
0.05%
CTRM NewCASTOR MARITIME INC$244,00093,525
+100.0%
0.03%
NewHEPION PHARMS INCcall$220,0001,110
+100.0%
0.03%
PALI NewPALISADE BIO INC$214,00052,500
+100.0%
0.03%
NewCASTOR MARITIME INCput$189,000726
+100.0%
0.03%
NOVN NewNOVAN INC$192,00019,132
+100.0%
0.03%
HCDIW NewHARBOR CUSTOM DEVELOPMENT IN*w$171,000272,103
+100.0%
0.02%
TVTX NewTRAVERE THERAPEUTICS INC$147,00010,042
+100.0%
0.02%
NewMETA MATERIALS INCput$136,000182
+100.0%
0.02%
NewREDHILL BIOPHARMA LTDcall$117,000170
+100.0%
0.02%
GOED New1847 GOEDEKER INC$110,00028,603
+100.0%
0.02%
NewEVOFEM BIOSCIENCES INCput$107,000945
+100.0%
0.02%
NewION GEOPHYSICAL CORPcall$105,000500
+100.0%
0.02%
New9 METERS BIOPHARMA INCcall$95,000862
+100.0%
0.01%
EVOK NewEVOKE PHARMA INC$65,00047,431
+100.0%
0.01%
TCDA NewTRICIDA INCcall$63,000146
+100.0%
0.01%
NewADAMIS PHARMACEUTICALS CORPcall$61,000553
+100.0%
0.01%
NewVASCULAR BIOGENICS LTDcall$47,000198
+100.0%
0.01%
NewATHERSYS INC NEWput$29,000204
+100.0%
0.00%
GROMW NewGROM SOCIAL ENTERPRISES INC*w$29,00029,471
+100.0%
0.00%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-08-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SPDR S&P 500 ETF TRUST UNIT37Q3 202349.1%
ISHARES TR35Q3 202352.2%
SPDR S&P BIOTECHNOLOGY32Q3 202212.8%
AMARIN CORP PLC30Q4 20212.0%
BIOGEN INC24Q1 202126.2%
SAREPTA THERAPEUTICS INC24Q3 20204.6%
BIOGEN INC23Q1 202113.7%
SAREPTA THERAPEUTICS INC22Q3 20206.2%
BRAINSTORM CELL THERAPEUTICS INC21Q3 20231.6%
VERTEX PHARMACEUTICALS INC20Q1 201812.6%

View SABBY MANAGEMENT, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
SABBY MANAGEMENT, LLC Q2 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
AGM GROUP HOLDINGS, INC.January 10, 2023627,9362.6%
Bit Digital, IncJanuary 10, 20233,166,9173.8%
Cingulate Inc.January 10, 2023105.0%
Context Therapeutics Inc.January 10, 2023796,7065.0%
HeartBeam, Inc.January 10, 2023271,7883.4%
PharmaCyte Biotech, Inc.January 10, 2023934,4565.0%
Rebus Holdings, Inc.Sold outJanuary 10, 202300.0%
TANTECH HOLDINGS LTDJanuary 10, 202341,5000.6%
Quanergy Systems, Inc.January 04, 2023936,9055.8%
TuanChe LtdJanuary 04, 20232,384,71310.0%

View SABBY MANAGEMENT, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-03
SC 13G2024-01-03
SC 13G2024-01-03
SC 13G2024-01-03

View SABBY MANAGEMENT, LLC's complete filings history.

Compare quarters

Export SABBY MANAGEMENT, LLC's holdings